These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 27505191)
21. Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff. Flood D; Mathieu I; Chary A; García P; Rohloff P BMC Health Serv Res; 2017 Jan; 17(1):27. PubMed ID: 28086866 [TBL] [Abstract][Full Text] [Related]
22. Knowledge and attitudes of physicians and pharmacists towards the use of generic medicines in Bosnia and Herzegovina. Čatić T; Avdagić L; Martinović I Med Glas (Zenica); 2017 Feb; 14(1):25-32. PubMed ID: 27917846 [TBL] [Abstract][Full Text] [Related]
23. Views and perceptions about locally manufactured medicines in Ethiopia: a qualitative study of physicians, patients and regulatory authorities. Alemayehu C; Mitchell G; Nikles J; Aseffa A; Clavarino A BMC Health Serv Res; 2018 Aug; 18(1):624. PubMed ID: 30089496 [TBL] [Abstract][Full Text] [Related]
24. "This body does not want free medicines": South African consumer perceptions of drug quality. Patel A; Gauld R; Norris P; Rades T Health Policy Plan; 2010 Jan; 25(1):61-9. PubMed ID: 19726560 [TBL] [Abstract][Full Text] [Related]
25. Generic Versions of Narrow Therapeutic Index Drugs: A National Survey of Pharmacists' Substitution Beliefs and Practices. Sarpatwari A; Lee MP; Gagne JJ; Lu Z; Dutcher SK; Jiang W; Campbell EG; Kesselheim AS Clin Pharmacol Ther; 2018 Jun; 103(6):1093-1099. PubMed ID: 29165800 [TBL] [Abstract][Full Text] [Related]
26. Lay views about medicines: the influence of the illness label for the use of generic versus brand. Figueiras MJ; Cortes MA; Marcelino D; Weinman J Psychol Health; 2010 Nov; 25(9):1121-8. PubMed ID: 20309776 [TBL] [Abstract][Full Text] [Related]
27. Generic medications for you, but brand-name medications for me. Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268 [TBL] [Abstract][Full Text] [Related]
28. Renal patients' views on generic prescribing and substitution: example from the United Arab Emirates. Al Ameri MN; Mohamed W; Makramalla E; Shalhoub B; Tucker A; Johnston A East Mediterr Health J; 2013 Apr; 19(4):373-81. PubMed ID: 23882964 [TBL] [Abstract][Full Text] [Related]
29. The impact of tamoxifen brand switch on side effects and patient compliance in hormone receptor positive breast cancer patients. Zeidan B; Anderson K; Peiris L; Rainsbury D; Laws S Breast; 2016 Oct; 29():62-7. PubMed ID: 27428472 [TBL] [Abstract][Full Text] [Related]
30. Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy. Makus KG; McCormick J Clin Ther; 2007 Feb; 29(2):334-41. PubMed ID: 17472825 [TBL] [Abstract][Full Text] [Related]
31. Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Quintal C; Mendes P Health Policy; 2012 Jan; 104(1):61-8. PubMed ID: 22024369 [TBL] [Abstract][Full Text] [Related]
32. Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review. Hassali MA; Wong ZY; Alrasheedy AA; Saleem F; Mohamad Yahaya AH; Aljadhey H Health Policy; 2014 Sep; 117(3):297-310. PubMed ID: 25129135 [TBL] [Abstract][Full Text] [Related]
33. Perceptions and patterns of use of generic drugs among Italian family pediatricians: first round results of a web survey. Fabiano V; Mameli C; Cattaneo D; Delle Fave A; Preziosa A; Mele G; Clementi E; Zuccotti GV Health Policy; 2012 Mar; 104(3):247-52. PubMed ID: 22217861 [TBL] [Abstract][Full Text] [Related]
34. Consumers' Perception of Generic Medicines and Evaluation of In Vitro Quality Control Parameters of Locally Manufactured Paracetamol Tablets in Asmara, Eritrea: A Cross-Sectional Study. Idris IM; Hassan DN; Hassen HA; Araya RZ; Weldemariam DG Biomed Res Int; 2021; 2021():6642826. PubMed ID: 34150909 [TBL] [Abstract][Full Text] [Related]
35. The Power of Labeling in Nocebo Effects. Faasse K; Martin LR Int Rev Neurobiol; 2018; 139():379-406. PubMed ID: 30146055 [TBL] [Abstract][Full Text] [Related]
36. Evaluating community pharmacists' perspectives and practices concerning generic medicines substitution in Saudi Arabia: A cross-sectional study. Alkhuzaee FS; Almalki HM; Attar AY; Althubiani SI; Almuallim WA; Cheema E; Hadi MA Health Policy; 2016 Dec; 120(12):1412-1419. PubMed ID: 28228231 [TBL] [Abstract][Full Text] [Related]
37. People's views on the level of agreement of generic medicines for different illnesses. Figueiras MJ; Marcelino D; Cortes MA Pharm World Sci; 2008 Oct; 30(5):590-4. PubMed ID: 18704749 [TBL] [Abstract][Full Text] [Related]
39. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan. Tsai YS; Lan SK; Ou JH; Tzai TS Clin Ther; 2007 Apr; 29(4):670-82. PubMed ID: 17617290 [TBL] [Abstract][Full Text] [Related]